JACOPIN / BSIP / SCIENCE PHOTO LIBRARY JACOPIN / BSIP / SCIENCE PHOTO LIBRARY
Illustration of the CAR-T cell membrane receptor, a T lymphocyte genetically modified for immunotherapy cancer treatment. The receptor bonds the cancer cells to the CAR-T cells triggering immune reactions, such as the production of cytokines, the expansion of lymphocytes, which contributes to the destruction of cancer cells.
Model release not required. Property release not required.